ABSTRACT
Lysosomes contribute to cellular homeostasis via processes including phagocytosis, macromolecule catabolism, secretion, and nutrient sensing mechanisms. Defective proteins related to lysosomal macromolecule catabolism are known to cause a broad range of lysosomal storage diseases. It is unclear, however, if mutations in genes in the autophagy-lysosomal pathway can cause syndromic disease. Here we show that SLC7A14, a transporter protein mediating lysosomal uptake of cationic amino acids, is evolutionarily conserved in vertebrate mechanosensitive hair cells and highly expressed in lysosomes of mammalian cochlear inner hair cells (IHCs) and retinal photoreceptors. Autosomal recessive mutation of SLC7A14 caused loss of IHCs and photoreceptors, leading to pre-synaptic auditory neuropathy and retinitis pigmentosa in mice and humans. Loss of function mutation altered protein trafficking and disrupted lysosomal homeostasis, resulting in dysregulation of basal autophagy and progressive cell degeneration. This study is the first to implicate autophagy-lysosomal dysfunction in syndromic hearing and vision loss in mice and humans.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NIH grant R01 DC016807 and the Bellucci Depaoli Family Foundation to DH. ZBJ is partly supported by the Beijing Natural Science Foundation (Z20J00122) and National Natural Science Foundation of China (81970838). YL is supported by National Natural Science Foundation of China (#81870718 and #81770996). The Imaging and Molecular Biology Cores at the Translational Hearing Research Center of Creighton University School of Medicine are supported by grant NIH grant 1P20GM139762-01 from the NIGMS and by Bellucci Depaoli Family Foundation. Human cochlear samples were provided by the NIDCD National Temporal bone laboratory at UCLA supported by NIDCD/NIH Grant U24: 1U24DC015910-01.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All mouse experiments were approved by the Creighton IACUC or Wenzhou Medical University and Capital Medical University in China. Other species used in vertebrate expression experiments included Tg(Pou4f3:GFP) zebrafish [Creighton University], brown leghorn chicken and red-eared slider turtle [Stanford University], and Sprague Dawley rat [NIH/NIDCD]. All animal procedures were approved by the respective institution animal care and use committees. The protocol was approved by the ethics committees of Wenzhou Medical University and Capital Medical University.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data generated in this study are included in the publication. Hearing and vision exams data from patients will be available upon request when the manuscript is accepted.
